Genomma Lab Internacional S.A.B. de C.V (MX:LABB) — Stock Price

MX$14.22 MXN
▼ -0.97% today

Genomma Lab Internacional S.A.B. de C.V (MX:LABB) is currently trading at MX$14.22 MXN, down 0.97% today. Over the past 52 weeks, shares have ranged between MX$14.06 and MX$23.20. This page tracks Genomma Lab Internacional S.A.B. de C.V's live share price on the MX exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Genomma Lab Internacional S.A.B. de C.V market capitalisation.

Genomma Lab Internacional S.A.B. de C.V (LABB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Genomma Lab Internacional S.A.B. de C.V's daily closing share price and trading volume on the MX exchange over the past year, giving a clear view of recent price momentum and liquidity.

Genomma Lab Internacional S.A.B. de C.V Income Statement — Revenue, Profit & Earnings by Year

Genomma Lab Internacional S.A.B. de C.V's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue MX$17.54 Billion MX$18.61 Billion MX$16.47 Billion MX$16.82 Billion MX$15.49 Billion
Cost of Revenue MX$6.52 Billion MX$6.68 Billion MX$6.38 Billion MX$6.66 Billion MX$5.92 Billion
Gross Profit MX$11.02 Billion MX$11.93 Billion MX$10.08 Billion MX$10.16 Billion MX$9.56 Billion
Research & Development — — — — —
SG&A MX$7.29 Billion MX$8.06 Billion MX$6.89 Billion MX$6.92 Billion MX$6.57 Billion
Total Operating Expenses MX$13.78 Billion MX$14.70 Billion MX$13.27 Billion MX$13.58 Billion MX$12.49 Billion
Operating Income MX$3.76 Billion MX$3.91 Billion MX$3.20 Billion MX$3.24 Billion MX$2.99 Billion
EBITDA — — — MX$3.01 Billion MX$2.84 Billion
EBIT — — — MX$3.24 Billion MX$3.06 Billion
Interest Expense MX$796.70 Million MX$887.80 Million MX$829.90 Million MX$525.64 Million MX$444.39 Million
Income Before Tax MX$2.43 Billion MX$2.89 Billion MX$1.72 Billion MX$2.26 Billion MX$2.22 Billion
Income Tax Expense — — — MX$867.61 Million MX$914.01 Million
Net Income MX$1.61 Billion MX$1.49 Billion MX$1.03 Billion MX$1.39 Billion MX$1.31 Billion

Genomma Lab Internacional S.A.B. de C.V Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Genomma Lab Internacional S.A.B. de C.V's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets MX$23.83 Billion MX$24.08 Billion MX$20.70 Billion MX$21.61 Billion MX$21.54 Billion
Total Current Assets MX$12.84 Billion MX$12.40 Billion MX$10.64 Billion MX$11.31 Billion MX$11.52 Billion
Cash & Equivalents — — — — —
Short-term Investments MX$213.62 Million MX$89.25 Million MX$183.23 Million MX$205.93 Million —
Net Receivables MX$4.50 Billion MX$4.44 Billion MX$3.71 Billion MX$4.27 Billion MX$4.23 Billion
Inventory MX$1.84 Billion MX$2.18 Billion MX$1.91 Billion MX$2.40 Billion MX$2.09 Billion
Property, Plant & Equipment — — — MX$3.59 Billion MX$3.37 Billion
Goodwill MX$45.81 Million MX$90.80 Million MX$90.80 Million MX$78.81 Million —
Total Liabilities MX$12.72 Billion MX$12.49 Billion MX$11.31 Billion MX$11.45 Billion MX$11.47 Billion
Total Current Liabilities MX$7.23 Billion MX$6.75 Billion MX$6.64 Billion MX$9.36 Billion MX$6.57 Billion
Long-term Debt MX$4.77 Billion MX$5.06 Billion MX$4.21 Billion MX$1.55 Billion MX$3.83 Billion
Net Debt MX$1.70 Billion MX$2.69 Billion MX$4.72 Billion MX$4.88 Billion MX$4.68 Billion
Total Stockholder Equity MX$11.11 Billion MX$11.59 Billion MX$9.38 Billion MX$10.15 Billion MX$10.07 Billion
Retained Earnings MX$12.22 Billion MX$12.21 Billion MX$10.77 Billion MX$10.05 Billion MX$9.42 Billion

Genomma Lab Internacional S.A.B. de C.V Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Genomma Lab Internacional S.A.B. de C.V generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow MX$2.05 Billion MX$3.03 Billion MX$1.77 Billion MX$2.05 Billion MX$1.47 Billion
Capital Expenditures MX$26.69 Million MX$675.03 Million MX$59.72 Million MX$402.96 Million MX$630.21 Million
Free Cash Flow MX$2.03 Billion MX$2.36 Billion MX$1.82 Billion MX$2.04 Billion MX$1.26 Billion
Investing Cash Flow — — — MX$-282.30 Million MX$-765.62 Million
Financing Cash Flow — — — MX$-1.36 Billion MX$-1.47 Billion
Dividends Paid MX$781.77 Million MX$778.82 Million MX$580.70 Million MX$777.66 Million MX$391.76 Million
Stock-Based Compensation — — — — —
Depreciation MX$379.14 Million MX$359.59 Million MX$246.43 Million MX$227.12 Million MX$170.27 Million
Change in Cash MX$826.34 Million MX$710.71 Million MX$911.65 Million MX$239.04 Million MX$-839.04 Million

Genomma Lab Internacional S.A.B. de C.V Earnings History — EPS Actual vs. Analyst Estimates

Track Genomma Lab Internacional S.A.B. de C.V's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 22, 2026 — 0.54 —
Apr 22, 2026 0.49 0.45 +8.89%
Feb 25, 2026 0.32 0.38 -15.79%
Oct 22, 2025 0.63 0.51 +23.53%
Jul 23, 2025 0.67 0.55 +21.82%
Apr 30, 2025 0.50 0.45 +11.11%
Feb 19, 2025 0.47 0.52 -9.62%
Oct 23, 2024 0.66 0.49 +34.69%